Product Introduction
Bioactivity


英文名: EBE-A22

描述: EBE-A22 (PD153035 Analog 63) 是 PD153035 衍生物，PD153035 能够抑制 ErbB-1 磷酸化，但对 EBE-A22 则无抑制作用。

激酶实验: GAL-021 is dissolved in DMSO, and final assay concentration of DMSO is 0.1% or less. The effects of GAL-021 (30 μM) on a panel of 55 receptors, transporters, and ion channels are evaluated using radioligand binding analyses. Potential kinase inhibition by GAL-021 (10 μM) is assessed using the Kinase HotSpot Screen where activity of 50 kinases is measured in the presence of adenosine triphosphate (10 μM)[1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 4.12 mg/mL (11.01 mM)


关键字: inhibit | Inhibitor | EBE-A-22 | EBE-A22 | EBE A22 | EBEA22

相关产品: EGFR/ErbB-2 inhibitor-1 | Neratinib maleate | Gefitinib | PP2 | EGFR-IN-1 hydrochloride | Osimertinib dimesylate | Tyrphostin AG 112 | PF-06459988 | BI-4020 | YS-363

相关库: JAK-STAT Compound Library | Anti-Prostate Cancer Compound Library | Anti-Breast Cancer Compound Library | Anti-Cancer Compound Library | Membrane Protein-targeted Compound Library | Anti-Lung Cancer Compound Library | Inhibitor Library | Kinase Inhibitor Library | Tyrosine Kinase Inhibitor Library | Anti-Pancreatic Cancer Compound Library